Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 964

1.

Profile of drug resistance mutations among HIV-1-infected Tunisian subjects failing antiretroviral therapy.

Jlizi A, Ben Ammar El Gaaied A, Slim A, Tebourski F, Ben Mamou M, Ben Chaabane T, Letaief-Omezzine A, Chakroun M, Garbouj M, Ben Rejeb S.

Arch Virol. 2008;153(6):1103-8. doi: 10.1007/s00705-008-0104-z.

PMID:
18483694
2.

Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain. The ERASE-2 Study Group.

Puig T, Pérez-Olmeda M, Rubio A, Ruiz L, Briones C, Franco JM, Gómez-Cano M, Stuyver L, Zamora L, Alvarez C, Leal M, Clotet B, Soriano V.

AIDS. 2000 Apr 14;14(6):727-32.

PMID:
10807196
3.

Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use. Investigators of the Quebec Primary Infection Study.

Salomon H, Wainberg MA, Brenner B, Quan Y, Rouleau D, Coté P, LeBlanc R, Lefebvre E, Spira B, Tsoukas C, Sekaly RP, Conway B, Mayers D, Routy JP.

AIDS. 2000 Jan 28;14(2):F17-23.

PMID:
10708278
4.

Drug resistant mutations detected by genotypic drug resistance testing in patients failing therapy in clade C HIV-1 infected individuals from India.

Kandathil AJ, Kannangai R, Verghese VP, Pulimood SA, Rupali P, Sridharan G, Grant P, Pillay D, Abraham OC.

Indian J Med Microbiol. 2009 Jul-Sep;27(3):231-6. doi: 10.4103/0255-0857.53205.

5.

Primary drug resistance in antiretroviral-naïve injection drug users.

Tossonian HK, Raffa JD, Grebely J, Viljoen M, Mead A, Khara M, McLean M, Krishnamurthy A, DeVlaming S, Conway B.

Int J Infect Dis. 2009 Sep;13(5):577-83. doi: 10.1016/j.ijid.2008.08.028.

6.

Primary HIV-1 resistance in recently and chronically infected individuals of the Italian Cohort Naive for Antiretrovirals.

Violin M, Forbici F, Cozzi-Lepri A, Velleca R, Bertoli A, Riva C, Giannella S, Manconi PE, Lazzarin A, Pasquinucci S, Tacconi L, Carnevale G, Mazzotta F, Bonazzi L, Montroni M, Chirianni A, Capobianchi M, Ippolito G, Moroni M, Perno CF, D'Arminio-Monforte A; I.CO.N.A. Study Group. Italian Cohort of Antiretroviral Naive patients..

J Biol Regul Homeost Agents. 2002 Jan-Mar;16(1):37-43.

PMID:
12003172
7.

Prevalence of mutations related to HIV-1 antiretroviral resistance in Brazilian patients failing HAART.

Tanuri A, Caridea E, Dantas MC, Morgado MG, Mello DL, Borges S, Tavares M, Ferreira SB, Santoro-Lopes G, Martins CR, Esteves AL, Diaz RS, Andreo SM, Ferreira LA, Rodrigues R, Reuter T, Cavalcanti AM, de Oliveira SM, de Barbosa HB, Teixeira PR, Chequer PN.

J Clin Virol. 2002 Jul;25(1):39-46.

PMID:
12126720
8.

Drug resistance at low viraemia in HIV-1-infected patients with antiretroviral combination therapy.

Aleman S, Söderbärg K, Visco-Comandini U, Sitbon G, Sönnerborg A.

AIDS. 2002 May 3;16(7):1039-44.

PMID:
11953470
9.

Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region: outcome after treatment in recently infected individuals.

Balotta C, Berlusconi A, Pan A, Violin M, Riva C, Colombo MC, Gori A, Papagno L, Corvasce S, Mazzucchelli R, Facchi G, Velleca R, Saporetti G, Galli M, Rusconi S, Moroni M.

Antivir Ther. 2000 Mar;5(1):7-14.

PMID:
10846586
10.

Testing genotypic and phenotypic resistance in human immunodeficiency virus type 1 isolates of clade B and other clades from children failing antiretroviral therapy.

Brindeiro PA, Brindeiro RM, Mortensen C, Hertogs K, De Vroey V, Rubini NP, Sion FS, De Sá CA, Machado DM, Succi RC, Tanuri A.

J Clin Microbiol. 2002 Dec;40(12):4512-9.

11.

The prevalence of resistance-associated mutations to protease and reverse transcriptase inhibitors in treatment-naïve (HIV1)-infected individuals in Casablanca, Morocco.

Bakhouch K, Oulad-Lahcen A, Bensghir R, Blaghen M, Elfilali KM, Ezzikouri S, Abidi O, Hassar M, Wakrim L.

J Infect Dev Ctries. 2009 Jun 1;3(5):380-91.

12.
14.

Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998: a French nationwide study.

Descamps D, Calvez V, Izopet J, Buffet-Janvresse C, Schmuck A, Colson P, Ruffault A, Maillard A, Masquelier B, Cottalorda J, Harzic M, Brun-Vézinet F, Costagliola D; ANRS Antiretroviral Resistance Study Group..

AIDS. 2001 Sep 28;15(14):1777-82.

PMID:
11579238
15.

Human immunodeficiency virus type 1 (HIV-1) genotyping in Rio de Janeiro, Brazil: assessing subtype and drug-resistance associated mutations in HIV-1 infected individuals failing highly active antiretroviral therapy.

Couto-Fernandez JC, Silva-de-Jesus C, Veloso VG, Rachid M, Gracie RS, Chequer-Fernandez SL, Oliveira SM, Arakaki-Sanchez D, Chequer PJ, Morgado MG.

Mem Inst Oswaldo Cruz. 2005 Feb;100(1):73-8.

16.

Antiretroviral drug resistance among HIV-1 infected children failing treatment.

Mullen J, Leech S, O'Shea S, Chrystie IL, Du Mont G, Ball C, Sharland M, Cottam F, Zuckerman M, Rice P, Easterbrook P.

J Med Virol. 2002 Nov;68(3):299-304.

PMID:
12226814
17.

[Evolution of HIV resistance mutations in the Valme referral center].

Nogales MC, Castro C, Martín-Mazuelos E.

Enferm Infecc Microbiol Clin. 2007 Feb;25(2):159. Spanish. No abstract available.

PMID:
17288915
18.

Drug resistance in patients experiencing early virological failure under a triple combination including indinavir.

Gallego O, de Mendoza C, Pérez-Elías MJ, Guardiola JM, Pedreira J, Dalmau D, Gónzalez J, Moreno A, Arribas JR, Rubio A, García-Arata I, Leal M, Domingo P, Soriano V.

AIDS. 2001 Sep 7;15(13):1701-6.

PMID:
11546946
19.

Patterns of resistance mutations to antiretroviral drugs in extensively treated HIV-1-infected patients with failure of highly active antiretroviral therapy.

Rousseau MN, Vergne L, Montes B, Peeters M, Reynes J, Delaporte E, Segondy M.

J Acquir Immune Defic Syndr. 2001 Jan 1;26(1):36-43. Erratum in: J Acquir Immune Defic Syndr 2001 Apr 1;26(4):395.

PMID:
11176267
20.

Temporal characterization of drug resistance associated mutations in HIV-1 protease and reverse transcriptase in patients failing antiretroviral therapy.

Santoro MM, Svicher V, Gori C, Zaccarelli M, Tozzi V, Forbici F, D'Arrigo R, Trotta MP, Bellocchi MC, Visco-Comandini U, Cenci A, Bertoli A, Narciso P, Antinori A, Perno CF, Ceccherini-Silberstein F.

New Microbiol. 2006 Apr;29(2):89-100.

PMID:
16841549
Items per page

Supplemental Content

Support Center